Status COVID-19/Flu A+B - FDA Extension Letter
During the COVID19 Pandemic, the FDA granted test manufactures 6 month for the product to expire. As the pandemic continued, evaluation of the test with formal review from the FDA allowed the manufactures to have an extension.
Attached is the most up to date released FDA extension for Status COVID-19/Flu A+B.
Related Articles
Lucira Pfizer COVID-19 & Flu Test - FDA Extension Letter
Do you have a Pfizer Inc. Lucira by Pfizer COVID-19 & Flu Home Test? These tests that are FDA authorized under emergency use authorization now have a longer shelf-life and the expiration dates for the tests have been extended. Attached you can find ...
CareStart COVID-19 OTC - FDA Extension Letter
During the COVID19 Pandemic, the FDA granted test manufactures 6 month for the product to expire. As the pandemic continued, evaluation of the test with formal review from the FDA allowed the manufactures to have an extension. Attached is the most up ...
BinaxNow Covid-19 Antigen Self Test - FDA Extension Letter
During the COVID19 Pandemic, the FDA granted test manufactures 6 month for the product to expire. As the pandemic continued, evaluation of the test with formal review from the FDA allowed the manufactures to have an extension of 15 months to ...
Indicaid Rapid Covid-19 Antigen Test - FDA Extension Letter
During the COVID19 Pandemic, the FDA granted test manufactures 6 month for the product to expire. As the pandemic continued, evaluation of the test with formal review from the FDA allowed the manufactures to have an extension. Attached is the most up ...
iHealth COVID-19 At Home Self Test - FDA Extension Letter
During the COVID19 Pandemic, the FDA granted test manufactures 6 month for the product to expire. As the pandemic continued, evaluation of the test with formal review from the FDA allowed the manufactures to have an extension. Attached is the most up ...